New Life Science Study Findings Recently Were Reported by Researchers at Johns Hopkins University Bloomberg School of Public Health (Formulary-Related Insurance Denials of Single-Source Branded Drugs in the United States): Life Science - Insurance News
• Researchers at the Johns Hopkins University Bloomberg School of Public Health published a new study on July 20, 2026, regarding formulary-related insurance denials for single-source branded drugs in the U.S. • The report highlights how drug utilization management tools, such as prior authorization, step therapy, and formulary exclusions, are used to reduce overall drug spending. • This is significant because while these measures lower costs for insurers, they may create critical barriers to patient access for essential branded medications.
insurancenewsnet.com







